IPO Trending
INFINIUMSME / NSEListed

Infinium Pharmachem Limited

Incorporated in 2003, Infinium Pharmachem Limited manufactures and supplies Iodine Derivatives, APIs, and iodination reaction-based bulk drugs. The company offers R&D services along with commercial-scale manufacturing and packaging for the pharmaceutical, agrochemical, nutraceutical, specialty chemicals, and other chemical industries. Its FDA-certified and GMP-compliant manufacturing facility in Gujarat spans 4,100 sq. m and is equipped to produce complex iodine derivatives. Infinium Pharmachem serves over 15 countries globally, offering more than 200 iodine derivatives and 7 APIs.

₹135 - ₹1351.84x sub
Listed Price141.50
Listing Gain+4.81%
TimelineFixed Price IPO
Open31 Mar 2023
Close05 Apr 2023
Allotment11 Apr 2023
Listing17 Apr 2023

Quota Reservation Portions

Market MakerPortion: 94,000 shares
5.01%
Nii (hni)Portion: 8,70,000 shares
46.4%
RetailPortion: 8,70,000 shares
46.4%
EmployeePortion: 41,000 shares
2.19%

Minimum Application Bracket Matrix

Retail1 lots / 1,000 shares
₹1,35,000
HNI2 lots / 2,000 shares
₹2,70,000

About the Company

Incorporated in 2003, Infinium Pharmachem Limited manufactures and supplies Iodine Derivatives, APIs, and iodination reaction-based bulk drugs. The company offers R&D services along with commercial-scale manufacturing and packaging for the pharmaceutical, agrochemical, nutraceutical, specialty chemicals, and other chemical industries. Its FDA-certified and GMP-compliant manufacturing facility in Gujarat spans 4,100 sq. m and is equipped to produce complex iodine derivatives. Infinium Pharmachem serves over 15 countries globally, offering more than 200 iodine derivatives and 7 APIs.

Company Promoters

Mr. Sanjaykumar Viththalbhai PatelMr. Pravin Bhadabhai MadhaniMr. Mitesh Lavjibhai Chikhaliya

Registrar

Bigshare Services Private Limited